Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema

NCT01119313 ↗

Phase 2 Completed 20 enrolled Almirall, S.A.

RandomizedFactorialDouble-blindTreatment

Summary

The aim of the study is an intra-individual comparison of skin conditions in addition to a patient based assessment of product appearance in the topical treatment of atopic eczema.

Timeline

Start: 2010-02
Primary completion: 2010-03
Completion: 2010-03

Publications

Ruzicka T, Willers C, Wigger-Alberti W. Efficacy and patient-reported outcomes of a new mometasone cream treating atopic eczema. Skin Pharmacol Physiol. 2012;25(6):305-12. doi: 10.1159/000341809. Epub 2012 Aug 31.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Mometasone	Other / unclassified	—	Topical
Comparator	Mometasone furoate	Other / unclassified	—	Topical

Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema

Summary

Timeline

Publications

Drugs

Indications